Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy

J Immunother Precis Oncol. 2024 Aug 19;7(3):171-177. doi: 10.36401/JIPO-24-1. eCollection 2024 Aug.

Sewanti Limaye^{1

2}, Mohan Menon², Shambhavi Singh¹, Pritam Kataria², Aditya V Shreenivas³, Rajan Datar⁴, Darshana Patil⁴, Prashant Kumar⁵, Niyati Shah^{1

2}, Hardik Sheth², Suku Sneha⁶, Chetan Madre^{1

2}, Ruturaj Deshpande^{1

2}, Narayan K Menon², Prasad Dandekar⁷, Vijay Haribhakti⁸

¹ Department of Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.
² Department of Medical Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.
³ Division of Hematology and Medical Oncology, Medical College of Wisconsin Cancer Centre, Milwaukee, Wisconsin, USA.
⁴ Datar Cancer Genetics, Nasik, India.
⁵ Karkinos Foundation, Mumbai, India.
⁶ Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁷ Department of Radiation Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.
⁸ Department of Surgical Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.

No abstract available

Keywords: immunotherapy; metronomic chemotherapy; recurrent metastatic head and neck cancer; solid tumors.